SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
MADRIGAL PHARMACEUTICALS, INC.
@MDGL_InsiderForm 4 Filing: Sibold William John Sells $1.4M of $MDGL
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
MADRIGAL PHARMACEUTICALS, INC.
Ticker: $MDGL
Transaction Value
$1.4M
Price/Share: $26.06
transaction date
2026-07-20
Shares: 52,500
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sibold William John, holds the title of President and CEO at MADRIGAL PHARMACEUTICALS, INC..
On 2026-07-20, the insider transacted 52,500 shares.The shares were transacted at a weighted average price of $26.06 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
Sibold William John (President and CEO) sold $1.4M of $MDGL
Post-Transaction Position: 209,810 shares
SEC Accession No: 0001628280-26-048919 (CIK: 1518611)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.